# Sitagliptin and Metformin Hydrochloride

NDC: 0781-5801
Generic name: Sitagliptin and Metformin Hydrochloride
Labeler / Manufacturer: Sandoz Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20251202

FDA application: ANDA202388

## Active ingredients

- METFORMIN HYDROCHLORIDE: 500 mg/1
- SITAGLIPTIN PHOSPHATE: 50 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0781-5801"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0781-5801
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a0fcdc08-0afc-4912-a126-3efea6bc8c61